Botulinum toxin treatment improves depression and anxiety but not sleep disturbance in cervical dystonia patients
This meta-analysis of 42 studies found that non-motor symptoms are highly prevalent in cervical dystonia, with sleep disturbance affecting 57.1% and fatigue 60.6% of patients. Botulinum toxin treatment produced modest improvements in depression (SMD = -0.31) and anxiety (SMD = -0.23), but no significant benefit for sleep disturbance.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Botulinum toxin treatment improves depression and anxiety but not sleep disturbance in cervical dystonia patients The current body of evidence comprises 1 study and 1 meta-analysis. EvidenceHub rates the overall confidence at 53/100 (low).
The Claim
Botulinum toxin treatment improves depression and anxiety but not sleep disturbance in cervical dystonia patients
This conclusion is most relevant to: Patients with cervical dystonia (CD).
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Prevalence and treatment effects on non-motor symptoms in cervical dystonia: A systematic review and meta-analysis. (Clinical parkinsonism & related disorders, 2026) —
How It Works
The proposed biological pathway:
- ▸Botulinum toxin injection reduces muscle spasms in cervical dystonia
- ▸Reduced muscle tension may alleviate physical discomfort and pain
- ▸Improved physical symptoms may lead to psychological relief, reducing depression and anxiety
- ▸No effect on sleep disturbance, suggesting sleep issues may be independent of motor symptoms
Who Might Benefit
Evidence fit by population:
- ▸Patients with cervical dystonia (CD)
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Substantial heterogeneity persisted across most analyses (I2 values 54.9% to 85.8%)
- ▸Assessment tool type was a major source of heterogeneity, indicating lack of standardized NMS assessment
- ▸Evidence base for NMS interventions remains preliminary, with few trials explicitly aimed at NMS
Frequently Asked Questions
What is the prevalence of sleep disturbance in cervical dystonia?▼
The pooled prevalence of sleep disturbance in cervical dystonia was 57.1% (95% CI, 46.7% to 67.2%).
Does botulinum toxin treatment improve depression in cervical dystonia?▼
Yes, botulinum toxin treatment produced a modest improvement in depression with a standardized mean difference of -0.31.
Does botulinum toxin treatment improve sleep disturbance in cervical dystonia?▼
No, the meta-analysis found no significant benefit of botulinum toxin treatment for sleep disturbance.
What was the most consistent source of heterogeneity in this meta-analysis?▼
Assessment tool type was the most consistent source of heterogeneity across outcomes, highlighting the need for standardized NMS assessment protocols.
References
- 1.Zhuang Z, Wang X, Fan S, Lv Q, Zhai J, Wang J, Li H. “Prevalence and treatment effects on non-motor symptoms in cervical dystonia: A systematic review and meta-analysis..” Clinical parkinsonism & related disorders, 2026. PMID: 42592252 DOI: 10.1016/j.prdoa.2026.100489